Interparfums, Inc.

NMS: IPAR
Live Quote

📈 ZcoreAI Score

Our AI model analyzes Interparfums, Inc.'s price action across multiple timeframes using regression channels and statistical scoring.

Get IPAR Z-Score →

About Interparfums, Inc.

Consumer Defensive Household & Personal Products
Interparfums, Inc., together with its subsidiaries, manufactures, markets, and distributes a range of fragrances and fragrance related products in the United States and internationally. It operates in two segments, European Based Operations and United States Based Operations. The company offers its fragrance and cosmetic products under the Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lanvin, Moncler, Montblanc, Rochas, Longchamp, Off-White, Van Cleef & Arpels, Abercrombie & Fitch, Anna Sui, Donna Karan, DKNY, Emanuel Ungaro, Ferragamo, Graff, GUESS, Hollister, MCM, Oscar de la Renta, Ungaro, and Roberto Cavalli brands, as well as French Connection, Intimate, Solférino, Tristar, and Lacoste trademarks. It sells its products to department stores, perfumeries, specialty stores, duty free shops, and domestic and international wholesalers and distributors, as well as through e-commerce sites. The company was formerly known as Jean Philippe Fragrances, Inc. and changed its name to Inter Parfums, Inc. in July 1999. Interparfums, Inc. was founded in 1982 and is headquartered in New York, New York.

📊 Fundamental Analysis

Interparfums, Inc. demonstrates exceptional profitability, with a profit margin of 11.3%.

The company recently reported 6.8% revenue growth, which is above average for the Consumer Defensive sector.

Return on Equity (ROE) is 20.3%, which exceeds the Consumer Defensive sector average, reflecting efficient capital allocation.

At a current price of $93.00, IPAR currently sits at the 24th percentile of its 52-week range (Range: $77.21 - $142.61).

💰 Valuation Insight

IPAR is valued broadly in line with the sector at a PE of 17.75. Analysts expect earnings growth, as indicated by a lower forward PE.

🏥 Financial Health

Profit Margin Excellent
Debt/Equity Excellent
Revenue Growth Excellent
⚠️ Return on Equity Moderate
⚠️ Beta (Risk) Moderate Volatility

Key Financials

Market Cap
$2.98B
Trailing P/E
17.75
Forward P/E
16.69
Beta (5Y)
1.27
52W High
$142.61
52W Low
$77.21
Avg Volume
266K
Day High
Day Low
Get IPAR Z-Score on Dashboard 🚀